Clinical Trial 45241

Santa Monica, CA 90404


Summary:

Exicure Merkel Cell Carcinoma Research Study

The Merkel cell carcinoma research study will evaluate how safe and tolerable a new investigational treatment is both alone and in combination with pembrolizumab in adults who qualify. The research study is open label and non-randomized. This means that you will know information about the active ingredients in the investigational treatment.

Eligible study participants:

  • Are at least 18 years or older
  • Are diagnosed by a doctor with Merkel cell carcinoma and had your disease worsen on the standard treatments (pembrolizumab (Keytruda ®) or avelumab (Bavencio ®)) as the most recent treatment
  • Have tumors on or under your skin, or in lymph nodes
  • Do not have other cancers at the same time
  • Do not have active or documented history of an autoimmune disease or syndrome requiring steroid or immunosuppressive treatment

Additional study requirements and exclusions may apply. A study representative will discuss these with you during the screening period.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.